Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites

被引:245
作者
De Vriese, C
Gregoire, F
Lema-Kisoka, R
Waelbroeck, M
Robberecht, P
Delporte, C
机构
[1] Free Univ Brussels, Fac Med, Dept Biochem & Nutr, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Fac Med, L Deloyers Lab Expt Surg, B-1070 Brussels, Belgium
关键词
D O I
10.1210/en.2004-0569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endogenous ligand for the GH secretagogue receptor is ghrelin, a peptide recently purified from the stomach. Ghrelin is n-octanoylated on the Ser(3) residue, and this modification is essential for its interaction with the receptor. The degradation of ghrelin by rat and human serum, purified commercial enzymes, and tissues homogenates was analyzed by combining HPLC and mass spectrometry. In serum, ghrelin was desoctanoylated, without proteolysis. The desoctanoylation was significantly reduced by phenylmethylsulfonyl fluoride, a serine proteases and esterases inhibitor. In rat serum, the carboxylesterase inhibitor bis-p-nitrophenyl-phosphate totally inhibited ghrelin desoctanoylation, and a correlation was found between ghrelin desoctanoylation and carboxylesterase activity. Moreover, purified carboxylesterase degraded ghrelin. Thus, carboxylesterase could be responsible for ghrelin desoctanoylation in that species. In human serum, ghrelin desoctanoylation was partially inhibited by eserine salicylate and sodium fluoride, two butyrylcholinesterase inhibitors, but not by bis-p-nitrophenyl-phosphate and EDTA. Purified butyrylcholinesterase was able to degrade ghrelin, and there was a correlation between the butyrylcholinesterase and ghrelin desoctanoylation activities in human sera. This suggested that several esterases, including butyrylcholinesterase, contributed to ghrelin desoctanoylation in human serum. In contact with tissues homogenates, ghrelin was degraded by both desoctanoylation and N-terminal proteolysis. We identified five cleavage sites in ghrelin between residues -Ser(2)-(acyl)Ser(3)- (stomach and liver), -(acyl?) Ser(3)-Phe(4)- (stomach, liver, and kidney), -Phe(4)-Leu(5)- (stomach and kidney), -Leu(5)-Ser(6)- and -Pro(7)-Glu(8)- (kidney). In all cases, the resulting fragments were biologically inactive.
引用
收藏
页码:4997 / 5005
页数:9
相关论文
共 52 条
  • [2] Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
    Asakawa, A
    Inui, A
    Kaga, T
    Yuzuriha, H
    Nagata, T
    Ueno, N
    Makino, S
    Fujimiya, M
    Niijima, A
    Fujino, MA
    Kasuga, M
    [J]. GASTROENTEROLOGY, 2001, 120 (02) : 337 - 345
  • [3] CLINICAL PHARMACOKINETICS OF PHYSOSTIGMINE IN PATIENTS WITH ALZHEIMERS-DISEASE
    ASTHANA, S
    GREIG, NH
    HEGEDUS, L
    HOLLOWAY, HH
    RAFFAELE, KC
    SCHAPIRO, MB
    SONCRANT, TT
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (03) : 299 - 309
  • [4] TURNOVER RATE OF PLASMA ARYL ESTERASE
    AUGUSTINSSON, K
    ASHEIM, A
    OLSSON, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1961, 49 (02) : 416 - &
  • [5] ARYLESTERASES
    AUGUSTINSSON, KB
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1964, 12 (10) : 744 - &
  • [6] Ghrelin and leptin pulse discharge in fed and fasted rats
    Bagnasco, M
    Kalra, PS
    Kalra, SP
    [J]. ENDOCRINOLOGY, 2002, 143 (02) : 726 - 729
  • [7] Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT
    Baldanzi, G
    Filigheddu, N
    Cutrupi, S
    Catapano, F
    Bonissoni, S
    Fubini, A
    Malan, D
    Baj, G
    Granata, R
    Broglio, F
    Papotti, M
    Surico, N
    Bussolino, F
    Isgaard, J
    Deghenghi, R
    Sinigaglia, F
    Prat, M
    Muccioli, G
    Ghigo, E
    Graziani, A
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 159 (06) : 1029 - 1037
  • [8] Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase
    Beaumont, NJ
    Skinner, VO
    Tan, TMM
    Ramesh, BS
    Byrne, DJ
    MacColl, GS
    Keen, JN
    Bouloux, PM
    Mikhailidis, DP
    Bruckdorfer, KR
    Vanderpump, MP
    Srai, KS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 8877 - 8880
  • [9] Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln 14-ghrelin
    Bedendi, I
    Alloatti, G
    Marcantoni, A
    Malan, D
    Catapano, F
    Ghé, C
    Deghenghi, R
    Ghigo, E
    Muccioli, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 476 (1-2) : 87 - 95
  • [10] Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a
    Bednarek, MA
    Feighner, SD
    Pong, SS
    McKee, KK
    Hreniuk, DL
    Silva, MV
    Warren, VA
    Howard, AD
    Van der Ploeg, LHY
    Heck, JV
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) : 4370 - 4376